| Literature DB >> 32893456 |
Mary P Moore1,2, Rory P Cunningham1,2, Ryan J Dashek1,3, Justine M Mucinski2, R Scott Rector1,2,4.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA-approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high-protein, plant-based, low-carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.Entities:
Mesh：
Year: 2020 PMID： 32893456 PMCID： PMC7511422 DOI： 10.1002/oby.22964
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN： 1930-7381 Impact factor: 5.002